Follicle-stimulating hormone is associated with non-alcoholic fatty liver disease in Chinese women over 55years old

Journal of Gastroenterology and Hepatology (Australia)

Volumn 31, Issue 6, 2016, Pages 1196-1202

  Wang, Ningjian ^a   Li, Qin ^a   Han, Bing ^a   Chen, Yi ^a   Zhu, Chunfang ^a   Chen, Yingchao ^a   Xia, Fangzhen ^a   Lu, Meng ^a   Meng, Ying ^a   Guo, Yuyu ^a   Ye, Lin ^a   Sui, Chunhua ^a   Kuang, Lin ^b   Lin, Dongping ^a   Lu, Yingli ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Follicle stimulating hormone; Non alcoholic fatty liver disease; Postmenopause

Indexed keywords

ESTRADIOL; FOLLITROPIN; SEX HORMONE; TESTOSTERONE; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CHINESE; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; NONALCOHOLIC FATTY LIVER; POSTMENOPAUSE; PRIORITY JOURNAL; PROBABILITY; WAIST CIRCUMFERENCE; AGE; BLOOD; CHI SQUARE DISTRIBUTION; CHINA; DIAGNOSTIC IMAGING; HEALTH SURVEY; INSULIN RESISTANCE; LUMINESCENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; ODDS RATIO; PREDICTIVE VALUE; PREVALENCE; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; STATISTICAL MODEL; VERY ELDERLY;

ADIPOSITY; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOMARKERS; CHI-SQUARE DISTRIBUTION; CHINA; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; HEALTH SURVEYS; HUMANS; INSULIN RESISTANCE; LOGISTIC MODELS; LUMINESCENT MEASUREMENTS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; ULTRASONOGRAPHY; WAIST CIRCUMFERENCE;

EID: 84971254251     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.13271     Document Type: Article

References (31)

1. Vassilatou E, Lafoyianni S, Vryonidou A et al. Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome. Hum. Reprod. 2010; 25: 212-20.
2. Saadeh S, Younossi ZM, Remer EM et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-50.
3. Fung J, Lee CK, Chan M et al. High prevalence of non-alcoholic fatty liver disease in the Chinese-results from the Hong Kong liver health census. Liver Int. 2015; 35: 542-9.
4. Cai W, Song JM, Zhang B, Sun YP, Yao H, Zhang YX. The prevalence of nonalcoholic fatty liver disease and relationship with serum uric acid level in Uyghur population. Scientific World Journal. 2014; 2014: 393628.
5. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment. Pharmacol. Ther. 2011; 34: 274-85.
6. Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E, Gastaldelli A. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 2013; 5: 1544-60.
7. Moscatiello S, Manini R, Marchesini G. Diabetes and liver disease: an ominous association. Nutr. Metab. Cardiovasc. Dis. 2007; 17: 63-70.
8. Bhatia LS, Curzen NP, Calder PC, Byrne CD. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Eur. Heart J. 2012; 33: 1190-200.
9. Anstee QM, Targher G, Day CP. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat. Rev. Gastroenterol. Hepatol. 2013; 10: 330-44.
10. Polyzos SA, Kountouras J, Tsatsoulis A et al. Sex steroids and sex hormone-binding globulin in postmenopausal women with nonalcoholic fatty liver disease. Hormones (Athens) 2013; 12: 405-16.
11. Hua X, Sun Y, Zhong Y et al. Low serum sex hormone-binding globulin is associated with nonalcoholic fatty liver disease in type 2 diabetic patients. Clin. Endocrinol. (Oxf) 2014; 80: 877-83.
12. Lazo M, Zeb I, Nasir K et al. Association between endogenous sex hormones and liver fat in a multiethnic study of atherosclerosis. Clin. Gastroenterol. Hepatol. 2015; 13: 1686-93 e2.
13. Wang N, Kuang L, Han B et al. Follicle-stimulating hormone associates with prediabetes and diabetes in postmenopausal women. Acta Diabetol. 2015. DOI: 10.1007/s00592-015-0769-1.
14. Freeman EW, Sammel MD, Lin H, Gracia CR. Obesity and reproductive hormone levels in the transition to menopause. Menopause 2010; 17: 718-26.
15. Stefanska A, Ponikowska I, Cwiklinska-Jurkowska M, Sypniewska G. Association of FSH with metabolic syndrome in postmenopausal women: a comparison with CRP, adiponectin and leptin. Biomark. Med. 2014; 8: 921-30.
16. Stefanska A, Sypniewska G, Ponikowska I, Cwiklinska-Jurkowska M. Association of follicle-stimulating hormone and sex hormone binding globulin with the metabolic syndrome in postmenopausal women. Clin. Biochem. 2012; 45: 703-6.
17. Wang N, Wang X, Han B et al. Is exposure to famine in childhood and economic development in adulthood associated with diabetes? J. Clin. Endocrinol. Metab. 2015. DOI: 10.1210/jc.2015-2750.
18. Golden SH, Dobs AS, Vaidya D et al. Endogenous sex hormones and glucose tolerance status in postmenopausal women. J. Clin. Endocrinol. Metab. 2007; 92: 1289-95.
19. Kalyani RR, Franco M, Dobs AS et al. The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women. J. Clin. Endocrinol. Metab. 2009; 94: 4127-35.
20. Bjørnerem A, Straume B, Midtby M et al. Endogenous sex hormones in relation to age, sex, lifestyle factors, and chronic diseases in a general population: the Tromso Study. J. Clin. Endocrinol. Metab. 2004; 89: 6039-47.
21. Li L, Wu J, Pu D et al. Factors associated with the age of natural menopause and menopausal symptoms in Chinese women. Maturitas 2012; 73: 354-60.
22. Xu Y, Wang L, He J et al. Prevalence and control of diabetes in Chinese adults. JAMA 2013; 310: 948-59.
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
24. Tian GX, Sun Y, Pang CJ et al. Oestradiol is a protective factor for non-alcoholic fatty liver disease in healthy men. Obes. Rev. 2012; 13: 381-7.
25. Pulzi FB, Cisternas R, Melo MR, Ribeiro CM, Malheiros CA, Salles JE. New clinical score to diagnose nonalcoholic steatohepatitis in obese patients. Diabetol. Metab. Syndr 2011; 3: 3.
26. Pang Q, Zhang JY, Song SD et al. Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index. World J. Gastroenterol. 2015; 21: 1650-62.
27. Fabbrini E, Magkos F, Mohammed BS et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc. Natl. Acad. Sci. U. S. A. 2009; 106: 15430-5.
28. Randolph JF Jr, Zheng H, Sowers MR et al. Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period. J. Clin. Endocrinol. Metab. 2011; 96: 746-54.
29. Kim C, Randolph JF, Golden SH et al. Weight loss decreases follicle stimulating hormone in overweight postmenopausal women. Obesity (Silver Spring) 2015; 23: 228-33.
30. Simpson ER. Aromatase: biologic relevance of tissue-specific expression. Semin. Reprod. Med. 2004; 22: 11-23.
31. Randolph JF Jr, Sowers M, Bondarenko IV, Harlow SD, Luborsky JL, Little RJ. Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. J. Clin. Endocrinol. Metab. 2004; 89: 1555-61.